SCHEMBL29988280

SCHEMBL29988280

CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)O)CC4)cn3)nc2n1C1CCCC1

nearest known ligand 0.81

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 16/20 0.81
CDK2 P24941 3/20 0.81
CCND3 P30281 3/20 0.81
GAK O14976 1/20 0.81
CCNT1 O60563 1/20 0.81
CCNA2 P20248 1/20 0.81
FECH P22830 1/20 0.81
CCND1 P24385 1/20 0.81
CDK9 P50750 1/20 0.81
CDK6 Q00534 1/20 0.81
CDK16 Q00536 1/20 0.81
MAP3K1 Q13233 1/20 0.81
CAMK2G Q13555 1/20 0.81
CAMK2D Q13557 1/20 0.81
Q6ZSR9 Q6ZSR9 1/20 0.81
PRKD2 Q9BZL6 1/20 0.81
SIK2 Q9H0K1 1/20 0.81
CDK1 P06493 6/20 0.78
HDAC1 Q13547 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2684165 1.00 CDK4 (0.81) CDK4CDK2CCND3GAKCCNT1
SCHEMBL28922801 0.95 CDK4 (0.80) CDK4CDK2CCND3GAKCCNT1
SCHEMBL30176589 0.93 CDK4 (0.81) CDK4CDK2CCND3GAKCCNT1
SCHEMBL303561 0.93 CDK4 (0.81) CDK4CDK2CCND3GAKCCNT1
SCHEMBL1999434 0.93 CDK4 (0.81) CDK4CDK2CCND3GAKCCNT1
SCHEMBL28622411 0.93 CDK4 (0.83) CDK4CDK2CCND3GAKCCNT1
SCHEMBL24994294 0.93 CDK4 (0.80) CDK4CDK2CCND3GAKCCNT1
SCHEMBL1999500 0.93 CDK4 (0.80) CDK4CDK2CCND3GAKCCNT1
SCHEMBL1989773 0.93 CDK4 (0.80) CDK4CDK2CCND3GAKCCNT1
SCHEMBL1991980 0.92 CDK4 (0.79) CDK4CDK2CCND3GAKCCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313987-B1 PROCESS FOR THE PREPARATION OF RIBOCICLIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF KRKA D D NOVO MESTO (SI) 2026-01-14 EP claimed
EP-4313987-A2 PROCESS FOR THE PREPARATION OF RIBOCICLIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF KRKA, d.d., Novo mesto (SI) 2024-02-07 EP claimed
WO-2022207788-A2 PROCESS FOR THE PREPARATION OF RIBOCICLIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF KRKA, D.D., NOVO MESTO (SI) 2022-10-06 WO claimed
EP-4313987-B1 PROCESS FOR THE PREPARATION OF RIBOCICLIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF KRKA D D NOVO MESTO (SI) 2026-01-14 EP disclosed
EP-4313987-A2 PROCESS FOR THE PREPARATION OF RIBOCICLIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF KRKA, d.d., Novo mesto (SI) 2024-02-07 EP disclosed
WO-2022207788-A2 PROCESS FOR THE PREPARATION OF RIBOCICLIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF KRKA, D.D., NOVO MESTO (SI) 2022-10-06 WO disclosed